von Willebrand factor clearance - biological mechanisms and clinical significance

被引:61
作者
O'Sullivan, Jamie M. [1 ]
Ward, Soracha [1 ]
Lavin, Michelle [1 ,2 ]
O'Donnell, James S. [1 ,2 ]
机构
[1] Royal Coll Surgeons Ireland, Irish Ctr Vasc Biol, Haemostasis Res Grp, Dublin, Ireland
[2] St James Hosp, Natl Coagulat Ctr, Dublin, Ireland
基金
爱尔兰科学基金会;
关键词
von Willebrand factor; von Willebrand disease; clearance; macrophage; FACTOR-VIII; ASIALOGLYCOPROTEIN RECEPTOR; DENDRITIC CELLS; IN-VIVO; ADAMTS13; PROTEOLYSIS; MACROPHAGE LECTIN; FACTOR PROPEPTIDE; FACTOR SURVIVAL; VWF PROPEPTIDE; PLASMA-LEVELS;
D O I
10.1111/bjh.15565
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The mechanisms involved in regulating von Willebrand factor (VWF) clearance remain poorly understood. However recent studies have shown that macrophages play a critical role in regulating the half-life of VWF, and have identified specific lectin (including asialoglycoprotein, macrophage galactose-type lectin, Sigec-5 and C-type lectin domain family 4 member M) and scavenger receptors (including low-density lipoprotein receptor-related protein-1, scavenger receptor A1 and stabilin-2) that are involved in VWF clearance. Further studies will be required to determine the relative importance of these individual receptors with respect to physiological and pathological VWF clearance. Nevertheless, recent clinical data have highlighted the importance of enhanced VWF clearance in the pathogenesis of type 1 von Willebrand disease (VWD). Moreover, increased clearance also contributes to reduced VWF levels in many patients with type 2 and type 3 VWD. Improved understanding regarding VWF clearance is not only of direct biological relevance, but may also have important implications for the development of novel therapeutic agents with extended plasma half-lives for the treatment of both VWD and haemophilia A.
引用
收藏
页码:185 / 195
页数:11
相关论文
共 83 条
[1]   CARBOHYDRATE-SPECIFIC RECEPTORS OF THE LIVER [J].
ASHWELL, G ;
HARFORD, J .
ANNUAL REVIEW OF BIOCHEMISTRY, 1982, 51 :531-554
[2]   von Willebrand factor clearance does not involve proteolysis by ADAMTS-13 [J].
Badirou, I. ;
Kurdi, M. ;
Rayes, J. ;
Legendre, P. ;
Christophe, O. D. ;
Lenting, P. J. ;
Denis, C. V. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2010, 8 (10) :2338-2340
[3]   Plasmin Cleaves Von Willebrand Factor at K1491-R1492 in the A1-A2 Linker Region in a Shear- and Glycan-Dependent Manner In Vitro [J].
Brophy, Teresa M. ;
Ward, Soracha E. ;
McGimsey, Thomas R. ;
Schneppenheim, Sonja ;
Drakeford, Clive ;
O'Sullivan, Jamie M. ;
Chion, Alain ;
Budde, Ulrich ;
O'Donnell, James S. .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2017, 37 (05) :845-+
[4]   Increased clearance of von Willebrand factor antigen post-DDAVP in type 1 von Willebrand disease: is it a potential pathogenic process? [J].
Brown, SA ;
Eldridge, A ;
Collins, PW ;
Bowen, DJ .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (08) :1714-1717
[5]   The plasma von Willebrand factor O-glycome comprises a surprising variety of structures including ABH antigens and disialosyl motifs [J].
Canis, K. ;
McKinnon, T. A. J. ;
Nowak, A. ;
Panico, M. ;
Morris, H. R. ;
Laffan, M. ;
Dell, A. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2010, 8 (01) :137-145
[6]   Mapping the N-glycome of human von Willebrand factor [J].
Canis, Kevin ;
McKinnon, Thomas A. J. ;
Nowak, Agata ;
Haslam, Stuart M. ;
Panico, Maria ;
Morris, Howard R. ;
Laffan, Mike A. ;
Dell, Anne .
BIOCHEMICAL JOURNAL, 2012, 447 :217-228
[7]   Clearance of von Willebrand factor [J].
Casari, C. ;
Lenting, P. J. ;
Wohner, N. ;
Christophe, O. D. ;
Denis, C. V. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 :202-211
[8]   Accelerated uptake of VWF/platelet complexes in macrophages contributes to VWD type 2B-associated thrombocytopenia [J].
Casari, Caterina ;
Du, Vivian ;
Wu, Ya-Ping ;
Kauskot, Alexandre ;
de Groot, Philip G. ;
Christophe, Olivier D. ;
Denis, Cecile V. ;
de Laat, Bas ;
Lenting, Peter J. .
BLOOD, 2013, 122 (16) :2893-2902
[9]   Reduced von Willebrand factor survival in type Vicenza von Willebrand disease [J].
Casonato, A ;
Pontara, E ;
Sartorello, F ;
Cattini, MG ;
Sartori, MT ;
Padrini, R ;
Girolami, A .
BLOOD, 2002, 99 (01) :180-184
[10]   Type 1 von Willebrand disease due to reduced von Willebrand factor synthesis and/or survival: observations from a case series [J].
Casonato, Alessandra ;
Gallinaro, Lisa ;
Cattini, Maria Grazia ;
Sartorello, Francesca ;
Pontara, Elena ;
Padrini, Roberto ;
Bertomoro, Antonella ;
Daidone, Viviana ;
Pagnan, Antonio .
TRANSLATIONAL RESEARCH, 2010, 155 (04) :200-208